Press-release for stocks in the health technology sector

Prices are updated after-hours

sector : Health technology

save search

Trevena Announces Approval of OLINVYK in China
Published: 2023-05-08 (Crawled : 11:00) - globenewswire.com
TRVN | $0.35 -4.37% -4.57% 170K

Health Technology

| -44.44% | O: 23.32% H: 322.19% C: 300.31%
approval olinvyk china

Endo, Inc. Announces Proposed Private Offering of Senior Secured Notes
Published: 2024-04-08 (Crawled : 12:00) - prnewswire.com
ENDPQ | $0.0006 -50.0% 3.4K

n/a

| 300.0% | O: -90.0% H: 300.0% C: 300.0%
offering

Endo, Inc. Announces Proposed New Senior Secured Credit Facilities
Published: 2024-04-01 (Crawled : 16:00) - prnewswire.com
ENDPQ | $0.0006 -50.0% 3.4K

n/a

| 900.0% | O: -75.0% H: 1900.0% C: 300.0%

Vivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep Apnea
Published: 2023-11-29 (Crawled : 12:30) - globenewswire.com
VVOS | $2.72 2.26% 2.21% 34K

Health Technology

| -38.04% | O: 171.75% H: 308.97% C: 243.67%
fda device treatment clearance therapeutics

Endo Announces Publication of New XIAFLEX® (collagenase clostridium histolyticum) Survey Data in Journal of Hand Surgery Global Open
Published: 2024-01-24 (Crawled : 12:30) - prnewswire.com
ENDPQ | $0.0006 -50.0% 3.4K

n/a

| 300.0% | O: -40.0% H: 200.0% C: 200.0%
xiaflex publication global

Precipio Launches its Rapid COVID-19 Antibody test on Amazon Platform
Published: 2021-05-03 (Crawled : 14:00) - globenewswire.com
PRPO A | $6.72 0.07% 1.7K

Health Technology

| 240.66% | O: 1.1% H: 169.02% C: 169.02%
covid test antibody amazon covid-19

Phio Pharmaceuticals Presents Positive New Data on PH-894 Demonstrating Antitumor Efficacy in Model of PD-1 Refractory Disease at the AACR Annual Meeting 2022
Published: 2022-04-08 (Crawled : 19:00) - biospace.com/
PHIO | $0.631 -1.07% -1.08% 29K

Health Technology

| -29.41% | O: -2.94% H: 175.0% C: 167.05%
ph-894 disease positive ph94

ASLAN Pharmaceuticals Provides TREK-DX Study Update and Highlights Potential of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients
Published: 2024-03-11 (Crawled : 11:00) - globenewswire.com
ASLN | News | $0.54 0.0% 26K

Health Technology

| -18.4% | O: 0.16% H: 203.51% C: 160.38%
dermatitis update pharmaceuticals potential study

Second Sight Medical Products, Inc. Receives FDA Approval for the Argus 2s Retinal Prosthesis System
Published: 2021-03-05 (Crawled : 15:00) - biospace.com/
EYES | $4.14 -0.24% 3.14%

Health Technology

| 189.51% | O: 60.14% H: 331.88% C: 152.84%
fda fda approval retina approval

Gritstone Advances Second Generation COVID-19 Vaccine “CORAL” Program with Support from NIAID; Program has Potential to Protect Against Mutant Variants of SARS-CoV-2
Published: 2021-01-19 (Crawled : 11:01) - globenewswire.com
GRTS | $0.7414 -0.31% -0.31% 1.5M

Health Technology

| -88.42% | O: 38.34% H: 154.19% C: 151.92%
covid vaccine potential sars-cov-2 program

Endo Announces Agreement with MAIA Pharmaceuticals to Distribute Bivalirudin Injection in Ready-to-Use Vials
Published: 2023-05-24 (Crawled : 13:00) - biospace.com/
ENDPQ | $0.0006 -50.0% 3.4K

n/a

| -92.0% | O: -60.0% H: 150.0% C: 150.0%
pharmaceuticals agreement injection

NeuroMetrix Receives FDA Breakthrough Device Designation for Treatment of Fibromyalgia with its Wearable Neurostimulation Technology
Published: 2021-07-20 (Crawled : 16:00) - biospace.com/
NURO | News | $4.28 17.26% 14.72% 250K

Health Technology

| 32.82% | O: 23.62% H: 197.77% C: 149.13%
treatment fda device technology fibromyalgia designation

Patient with Candida krusei Infection in Matinas BioPharma’s Oral MAT2203 Expanded Access Program Achieves Complete Clinical Resolution
Published: 2023-10-11 (Crawled : 12:00) - globenewswire.com
MTNB | $0.1877 -1.21% 0.0% 330K

Health Technology

| 22.58% | O: 74.26% H: 229.51% C: 137.32%
mat2203 infection program

LIXTE BIOTECHNOLOGY HOLDINGS, INC. REPORTS THAT ITS LEAD CLINICAL COMPOUND, LB-100, CAN KILL CANCER CELLS THROUGH HYPER-STIMULATION OF CELL PROLIFERATION SIGNALS IN PRE-CLINICAL MODELS
Published: 2023-02-07 (Crawled : 18:00) - globenewswire.com
LIXT | $3.351 4.68% 11K

Health Technology

| 326.74% | O: -1.33% H: 237.5% C: 136.25%
lb-100 pre-clinical cancer wee1 kinase stimulates the signals modest toxicity

Updated Results from the Phase 1/2 Study of ESSA's Lead Candidate EPI-7386 in Combination with Enzalutamide Highlighted at the 29th Annual Prostate Cancer Foundation Scientific Retreat
Published: 2022-10-26 (Crawled : 14:00) - biospace.com/
EPIX | $6.57 -2.23% -2.28% 100K

Health Technology

| 267.44% | O: 19.19% H: 148.78% C: 135.12%
epi-7386 candidate results cancer study prostate cancer phase 1

ESSA Pharma Presents Preclinical Data for its First Generation Androgen Receptor N-Terminal Domain Degrader at the 34th EORTC-NCI-AACR Symposium
Published: 2022-10-26 (Crawled : 22:00) - biospace.com/
EPIX | $6.57 -2.23% -2.28% 100K

Health Technology

| 267.44% | O: 19.19% H: 148.78% C: 135.12%
pharma preclinical symposium

NanoVibronix Receives FDA 510(k) Premarket Clearance for PainShield Plus
Published: 2022-11-28 (Crawled : 23:00) - biospace.com/
NAOV 4 | $0.746 -0.53% -0.54% 33K

Health Technology

| -84.56% | O: 4.21% H: 138.89% C: 134.41%
fda clearance plus painshield

Nemaura Medical Announces Order for 200,000 sugarBEAT® Sensors
Published: 2021-05-05 (Crawled : 13:15) - biospace.com/
NMRD | $0.0798 -28.78% 28K

Health Technology

| -98.3% | O: 3.62% H: 143.94% C: 127.1%
sensor order

Endo Announces Approval of XCOPRI™ (cenobamate tablets) in Canada
Published: 2023-06-29 (Crawled : 12:20) - biospace.com/
ENDPQ | $0.0006 -50.0% 3.4K

n/a

| -80.0% | O: -50.0% H: 150.0% C: 125.0%
approval canada

Endo Announces First Patient Enrolled in Registry of Peyronie's Disease
Published: 2023-07-20 (Crawled : 13:00) - biospace.com/
ENDPQ | $0.0006 -50.0% 3.4K

n/a

| -56.04% | O: 0.0% H: 147.25% C: 119.78%
disease